San Diego
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, opened its new headquarters and research facility in San Diego in December of 2015. Consolidating three previous offices, the 34,000-sf project houses over 50 employees and all of OncoSec's discovery research, clinical, and administrative activities under one roof. The facility features approximately 15,000 sf of technology-rich lab space that is strategically arranged to optimize workflow and minimize potential disruptions. Developed by Alexandria Real Estate Equities, the building features recycled materials, drought-tolerant vegetation, and a recycled water irrigation system.
Source
